BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32495872)

  • 1. High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma.
    Wang HF; Lv JQ; Li HH; Wang W; Lin FQ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5378-5384. PubMed ID: 32495872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
    Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased long non-coding RNA ARAP1-AS1 expression and its prognostic significance in human gastric cancer: a preliminary study.
    Jiang YH; Zhu XY; Guo ZY; Yang ZH
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1815-1820. PubMed ID: 32141550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.
    Chen M; Wu X; Ma W; Zhou Q; Wang X; Zhang R; Wang J; Yang X
    Cancer Biomark; 2017 Dec; 21(1):23-28. PubMed ID: 29036784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
    Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
    Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
    Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis.
    Huang D; Zhang K; Zheng W; Zhang R; Chen J; Du N; Xia Y; Long Y; Gu Y; Xu J; Deng M
    J Exp Clin Cancer Res; 2021 Oct; 40(1):342. PubMed ID: 34706749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.
    Chen LL; He J; Qiu XT; Yu J; Wang ZM
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1063-1068. PubMed ID: 30779073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
    Shi XY; Sun YZ; Li M; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the long noncoding RNA ADPGK-AS1 promotes carcinogenesis and predicts poor prognosis in gastric cancer.
    Huang Z; Yang H
    Biochem Biophys Res Commun; 2019 May; 513(1):127-134. PubMed ID: 30944080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
    Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
    J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
    Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
    J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
    Xu F; Li H; Hu C
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification.
    Duan F; Li Y; Feng Y; Niu G; Chai J; Wang K
    Cancer Med; 2023 Feb; 12(4):4227-4235. PubMed ID: 36164273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of long noncoding RNA SAMMSON in the clinicopathologic features and the prognostic implications of human gastric cancer.
    Sun SB; Lin SX; Cao HL; Xiao ZQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6080-6087. PubMed ID: 32572923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.